New AI solution is being used by companies such as biorefinery uisa and revolutionizes API management, governance and integrations.
MIAMI--(BUSINESS WIRE)-- Sensedia, a global leader in API and integration solutions, today announced the launch of Sensedia AI Copilot, a groundbreaking AI assistant designed to facilitate all steps of API Management, Governance and Application Integrations.
The solution embeds over 17 years of Sensedia's expertise in designing API... (continue reading...)
- The advisory committee offers valuable non-binding recommendations for the FDA
- Blood test offers a convenient non-invasive screening option that overcomes barriers associated with current non-invasive screening tests
- Shield remains on track to become the first FDA-approved blood test that meets performance requirements for Medicare coverage1
PALO ALTO, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company,... (continue reading...)
WARRENDALE, Pa.--(BUSINESS WIRE)-- Limbach Holdings, Inc. (Nasdaq: LMB) (“Limbach” or the “Company”), the building systems solutions firm, today announced that President and Chief Executive Officer Michael McCann will participate in the Stifel Cross Sector Insight Conference in Boston. McCann will host one-on-one meetings with investors June 4-5.
Investors participating in the conference who wish to meet with McCann should contact conference organizers at ... (continue reading...)
MILL VALLEY, Calif.--(BUSINESS WIRE)-- Four Corners Property Trust (NYSE: FCPT), a real estate investment trust primarily engaged in the ownership and acquisition of high-quality, net-leased restaurant and retail properties (“FCPT” or the “Company”), is pleased to announce the acquisition of eight Mavis Tire and affiliated operated properties for $20 million via a sale-leaseback. The properties are located across Alabama (2), Georgia (2), Louisiana (1), New... (continue reading...)
Request reflects Aqua’s commitment to reliability and service for customers
BRYN MAWR, Pa.--(BUSINESS WIRE)-- Aqua Pennsylvania Inc. (Aqua) filed an application with the Pennsylvania Public Utility Commission (PUC) today requesting an adjustment in water and wastewater rates for its customers. This rate request reflects recovery of the $953 million in infrastructure investments through the end of 2025 and highlights Aqua’s commitment to improving reliability... (continue reading...)
More Business Wire
View Older Stories-
Browning West Announces Successful Replacement of Gildan Activewear’s Entire Board of Directors with Full Eight-Member Slate
-
Golden Entertainment Announces Repricing of Term Loan
-
Luskin Orthopaedic Institute for Children (LuskinOIC) Stand For Kids Gala Honors the Los Angeles Chargers and Students Run LA on the 50-yard Line of SoFi Stadium on June 8, 2024
-
Power Integrations to Present at Upcoming Investor Conferences
-
SSR Mining Announces Voting Results From 2024 Annual and Special Meeting of Shareholders
-
Pan American Silver Releases 2023 Sustainability Report
-
Crypto Specialist Bitwise’s First-Ever Spot Ethereum ETF Receives Key SEC Approval
-
Pei enters the MSCI COLCAP index
-
Oklo Partners with Wyoming Hyperscale to Deliver 100 Megawatts to its Data Centers
-
Puma Biotechnology Announces Publication of Alisertib Abstract Titles for the 2024 ASCO Annual Meeting
-
Flatiron Health Announces Research to Be Presented at American Society of Clinical Oncology 2024 Annual Meeting
-
NW Natural Holdings and NW Natural CEO David H. Anderson Announces Retirement
-
Nimbus Therapeutics Presents New Positive Monotherapy Phase 1/2 Clinical Data of HPK1 Inhibitor in Treatment of Advanced Solid Tumors at 2024 ASCO Annual Meeting
-
Breakthrough Data on Botensilimab/Balstilimab in MSS CRC Presented at the 2024 ASCO Annual Meeting
-
Barnes & Noble Education Announces Preliminary Fiscal Year 2024 Results
-
Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel
-
Aulos Bioscience Provides Positive Interim Phase 1/2 Data From AU-007 at 2024 ASCO Annual Meeting
-
TIGER Study Reports New TTFields Therapy Survival Results for Newly Diagnosed Glioblastoma Patients in Germany
-
Bicycle Therapeutics to Present Pharmacokinetic and Safety Evaluation of Lead BTC® Molecules in Phase 1/2 Trials at the 2024 ASCO Annual Meeting
-
TelevisaUnivision Announces Pricing of $1.0 Billion Debt
-
BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc. Declares Distribution
-
KBRA Assigns AAA Rating, Stable Outlook to the New Mexico Finance Authority State Transportation Revenue Refunding Bonds (State Transportation Commission - Senior Lien), Series 2024A
-
Stellar Bancorp, Inc. Declares Quarterly Dividend and New Share Repurchase Program
-
Verastem Oncology Announces Positive Initial Interim Safety and Efficacy Results from RAMP 205 Trial Evaluating Avutometinib Plus Defactinib in Combination with Gemcitabine and Nab-paclitaxel in First
-
NMDP and CIBMTR to Present New, Promising Stem Cell Transplantation Trial Data using Mismatched, Unrelated Donors at 2024 ASCO Annual Meeting
-
Iambic Therapeutics Announces Poster Presentation for IAM1363, a Clinical Stage Type II HER2 Inhibitor, at the 2024 ASCO Annual Meeting
-
Genmab to Showcase Data in Various Patient Populations to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting
-
SOTIO Presents Overview of DUET-01 Phase 1/2 Study at ASCO Annual Meeting
-
Legend Biotech to Highlight Leadership in CAR-T Cell Therapy for Patients with Multiple Myeloma at ASCO and EHA
-
Orca Bio to Present Positive Clinical Outcomes with Orca-T in Patients with AML at 2024 ASCO Annual Meeting
-
Xspray to present data at ASCO highlighting frequent comedication of PPIs with TKIs in CML-patients and greater than expected negative effects on the bioavailability of crystalline dasatinib
-
City of Hope Researchers to Present Investigational Treatments for Colorectal, Kidney and Blood Cancers at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Obsidian Therapeutics Announces Positive Clinical Data from OBX-115 in Patients with Advanced Melanoma at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Comvest Partners Announces $70 Million Senior Credit Facility For Nationwide Energy Partners to Support Growth Strategy
-
EMD Serono to Showcase Advances in the Science of Cancer With New Data Presented at ASCO 2024
-
NeraCare Announces Publication of Abstract on Clinical Validation of a Prognostic 7-Biomarker Assay for Prediction of Relapse in Patients with Early-Stage Cutaneous Melanoma at the 2024 American Socie
-
AffyImmune Announces Confirmed Complete Response in Patient with Anaplastic Thyroid Cancer
-
Menarini Group Presents Updated Data from ELECTRA and ELEVATE Combination Studies of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2024 Annual Meeting
-
Incendia Therapeutics Announces Upcoming Presentation with PathAI at the 2024 American Society of Clinical Oncology Annual Meeting
-
Klaviyo to Present at the William Blair Growth Stock Conference
-
Dentalcorp Announces Annual General Meeting Voting Results
-
Ligand to Participate in Upcoming Investor Conferences
-
Genworth Financial Announces Results of Annual Meeting
-
Phreesia’s Amy Patel Named One of PM360’s 2024 ELITE 100
-
Alerus Financial Corporation Declares Cash Dividend on Common Shares
-
Enhabit Provides Additional Details on Robust Strategic Review Process
-
Lincoln National Corporation's Board of Directors Declares Quarterly Cash Dividend
-
Caleres Declares Regular Quarterly Dividend
-
Stevanato Group to Present at Upcoming Investor Conferences
-
Sallie Mae CFO to Speak at TD Financial Services & Fintech Summit